Chemical inhibitors of acyl-CoA thioesterase 3 utilize a variety of mechanisms to reduce the protein's activity. Triacsin C directly targets the biosynthesis pathway of acyl-CoA by inhibiting long-chain acyl-CoA synthetase, leading to a reduced availability of the acyl-CoA substrate necessary for the enzymatic function of acyl-CoA thioesterase 3. Similarly, AICAR activates AMP-activated protein kinase, which in turn enhances fatty acid oxidation, resulting in the depletion of acyl-CoA substrates and a consequent decrease in acyl-CoA thioesterase 3 activity. Nicotinic Acid acts upstream by inhibiting lipolysis, which is the breakdown of lipids into free fatty acids, subsequently leading to lower production of acyl-CoA molecules. In this way, Nicotinic Acid indirectly limits the substrate availability for acyl-CoA thioesterase 3.
Perhexiline, Etomoxir, Oxfenicine, and Malonyl-CoA share a common mechanism of inhibiting carnitine palmitoyltransferase-1 (CPT-1), an enzyme critical for transporting acyl-CoAs into mitochondria for β-oxidation. This inhibition leads to an accumulation of acyl-CoAs within the cytosol. The resultant high levels of acyl-CoAs can saturate acyl-CoA thioesterase 3 and impede its function due to substrate inhibition. On the other hand, Mildronate inhibits gamma-butyrobetaine hydroxylase, which reduces carnitine synthesis, thereby decreasing the transport of acyl-CoA into the mitochondria and indirectly reducing the activity of acyl-CoA thioesterase 3 by limiting its substrate. Guggulsterone affects lipid metabolism, which can lead to a decrease in acyl-CoA synthesis and a consequent reduction in acyl-CoA thioesterase 3 activity by decreasing substrate availability. Fenofibrate activates peroxisome proliferator-activated receptor alpha, which regulates fatty acid oxidation, thereby potentially leading to a reduction in acyl-CoA levels and an indirect inhibition of acyl-CoA thioesterase 3. Curcumin influences various metabolic pathways that can result in altered acyl-CoA levels, again affecting the activity of acyl-CoA thioesterase 3. These diverse compounds, through their distinct actions, all contribute to the modulation of acyl-CoA thioesterase 3 activity by affecting the levels of its substrates.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triacsin C Solution in DMSO | 76896-80-5 | sc-200574 sc-200574A | 100 µg 1 mg | $187.00 $843.00 | 14 | |
Inhibits long-chain acyl-CoA synthetase, reducing the synthesis of acyl-CoA, thereby indirectly inhibiting acyl-CoA thioesterase 3 by substrate depletion. | ||||||
rac Perhexiline Maleate | 6724-53-4 | sc-460183 | 10 mg | $188.00 | ||
Inhibits mitochondrial carnitine palmitoyltransferase-1 (CPT-1), leading to an accumulation of acyl-CoAs, potentially causing substrate inhibition of acyl-CoA thioesterase 3. | ||||||
(+)-Etomoxir sodium salt | 828934-41-4 | sc-215009 sc-215009A | 5 mg 25 mg | $151.00 $506.00 | 3 | |
Inhibits CPT-1 and could therefore increase acyl-CoA levels, indirectly saturating and inhibiting acyl-CoA thioesterase 3. | ||||||
4-Hydroxy-L-phenylglycine | 32462-30-9 | sc-254680A sc-254680 | 5 g 10 g | $82.00 $109.00 | ||
Inhibits CPT-1, which could lead to increased acyl-CoA concentrations, thus potentially inhibiting acyl-CoA thioesterase 3 through substrate inhibition. | ||||||
Meldonium | 76144-81-5 | sc-207887 | 100 mg | $455.00 | 1 | |
Inhibits gamma-butyrobetaine hydroxylase, reducing carnitine synthesis and thus acyl-CoA transport into mitochondria, leading to indirect inhibition of acyl-CoA thioesterase 3 by decreasing substrate availability. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMP-activated protein kinase which enhances fatty acid oxidation, this can deplete acyl-CoA substrates, thus inhibiting acyl-CoA thioesterase 3 activity. | ||||||
Rimonabant | 168273-06-1 | sc-205491 sc-205491A | 5 mg 10 mg | $73.00 $163.00 | 15 | |
Antagonizes cannabinoid receptor 1, which plays a role in lipid metabolism, could lead to reduced synthesis of fatty acids and acyl-CoAs, indirectly inhibiting acyl-CoA thioesterase 3 by lowering substrate levels. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Induces lipolysis inhibition, which could decrease free fatty acid and subsequent acyl-CoA levels, indirectly inhibiting acyl-CoA thioesterase 3. | ||||||
Guggulsterone | 95975-55-6 | sc-203990 sc-203990A | 10 mg 50 mg | $145.00 $615.00 | 1 | |
Acts on lipid metabolism, possibly decreasing acyl-CoA synthesis and thus inhibiting acyl-CoA thioesterase 3 indirectly by reducing substrate availability. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Activates peroxisome proliferator-activated receptor alpha which regulates fatty acid oxidation, this can lead to decreased acyl-CoA levels, thereby indirectly inhibiting acyl-CoA thioesterase 3 activity. | ||||||